Advertisement

Medtronic plc MDT

Set alert

Price alert · MDT

All alert types
99.29 USD +2.75 +2.85%

At close · Nov 2

98.81 -0.48 -0.48%

After hours · Nov 2, 4:00 PM ET

Bid
99.30 × 200
Ask
99.31 × 100
96.75 Day range 99.47
73.31 52-week range 106.33
YTD
+3.36%
1 year
+9.47%
Open
96.94
Prev close
96.54
Mkt cap
127.01B
Vol
8.29M
Avg vol
16.42M
EPS
4.07
P/E
24.40
Div yield
2.98%
More statistics
Low
96.75
High
99.47
Forward P/E
15.50
Beta
0.57
Short ratio
4.63
Inst. own
88.76%
Dividend
2.88
Ex-div date
Sep 24, 2026
Earnings
Nov 17, 2026
50-d avg
91.70
200-d avg
88.16
1y target
104.62

5Y chart

Chart tools
Interval

Events in this range
  • Dec 21, 2021Dividend: 0.63
  • Mar 24, 2022Dividend: 0.63
  • Jun 23, 2022Dividend: 0.68
  • Sep 22, 2022Dividend: 0.68
  • Dec 20, 2022Dividend: 0.68
  • Jan 13, 2023Dividend: 0.68
  • Mar 23, 2023Dividend: 0.68
  • Jun 22, 2023Dividend: 0.69
  • Sep 21, 2023Dividend: 0.69
  • Dec 19, 2023Dividend: 0.69
  • Dec 20, 2023Dividend: 0.69
  • Mar 21, 2024Dividend: 0.69
  • Mar 22, 2024Dividend: 0.69
  • Jun 28, 2024Dividend: 0.7
  • Sep 27, 2024Dividend: 0.7
  • Dec 27, 2024Dividend: 0.7
  • Mar 28, 2025Dividend: 0.7
  • Jun 27, 2025Dividend: 0.71
  • Aug 19, 2025Earnings: 1.26; estimate 1.23; surprise 2.44%
  • Sep 26, 2025Dividend: 0.71
  • Nov 18, 2025Earnings: 1.36; estimate 1.31; surprise 3.82%
  • Dec 26, 2025Dividend: 0.71
  • Feb 17, 2026Earnings: 1.36; estimate 1.34; surprise 1.49%
  • Mar 27, 2026Dividend: 0.71
  • Jun 3, 2026Earnings: 1.55; estimate 1.54; surprise 0.65%
  • Jun 26, 2026Dividend: 0.72
  • Sep 1, 2026Earnings: 1.45; estimate 1.39; surprise 4.32%
  • Sep 2, 2026Rating: Wells Fargo · Overweight → Overweight
  • Sep 2, 2026Rating: Truist Securities · Hold → Hold
  • Sep 3, 2026Rating: UBS · Buy → Buy
  • Sep 25, 2026Dividend: 0.72
  • Sep 30, 2026Rating: TD Cowen · Buy → Buy
  • Oct 7, 2026Rating: Barclays · — → Equal-Weight
  • Oct 12, 2026Rating: BTIG · Buy → Buy
Signals (94)
NameDateAgo
SMA: BullishOct 12, 20263 weeks ago
SMA: BearishSep 21, 20261 month ago
SMA: BullishAug 3, 20263 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 1, 20265 months ago
RSI: OversoldMay 25, 20265 months ago
RSI: OversoldApr 27, 20266 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BearishFeb 16, 20268 months ago
MACD: Sell SignalFeb 16, 20268 months ago
MACD: Buy SignalJan 26, 20269 months ago
SMA: BullishJan 19, 20269 months ago
MACD: Sell SignalDec 29, 202510 months ago
SMA: BearishDec 22, 202510 months ago
RSI: OverboughtNov 24, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
SMA: BullishNov 10, 202511 months ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BearishOct 20, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 23, 20251 year ago
MACD: Buy SignalJun 16, 20251 year ago
SMA: BullishJun 2, 20251 year ago
SMA: BullishJun 2, 20251 year ago
SMA: BearishMay 19, 20251 year ago
SMA: BullishMay 12, 20251 year ago
MACD: Sell SignalMar 31, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BearishMar 17, 20251 year ago
MACD: Buy SignalJan 27, 20251 year ago
SMA: BullishJan 13, 20251 year ago
SMA: BullishJan 13, 20251 year ago
SMA: BearishDec 2, 20241 year ago
MACD: Sell SignalNov 11, 20241 year ago
SMA: BearishNov 4, 20241 year ago
SMA: BullishAug 12, 20242 years ago
MACD: Buy SignalAug 12, 20242 years ago
SMA: BullishJul 29, 20242 years ago
SMA: BearishJun 10, 20242 years ago
SMA: BearishJun 10, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BearishMay 20, 20242 years ago
SMA: BearishMay 20, 20242 years ago
SMA: BullishMay 6, 20242 years ago
SMA: BullishApr 29, 20242 years ago
SMA: BearishApr 8, 20242 years ago
MACD: Sell SignalApr 8, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishMar 25, 20242 years ago
SMA: BearishFeb 26, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BearishFeb 12, 20242 years ago
SMA: BullishDec 11, 20232 years ago
MACD: Buy SignalNov 27, 20232 years ago
SMA: BullishNov 20, 20232 years ago
RSI: OversoldOct 23, 20233 years ago
MACD: Sell SignalAug 7, 20233 years ago
SMA: BearishJul 31, 20233 years ago
SMA: BearishJul 31, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BearishJul 3, 20233 years ago
SMA: BullishJun 12, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BullishApr 17, 20233 years ago
SMA: BullishApr 17, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishFeb 13, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BullishJan 2, 20233 years ago
MACD: Buy SignalJan 2, 20233 years ago
MACD: Sell SignalNov 21, 20223 years ago
SMA: BearishOct 31, 20224 years ago
MACD: Buy SignalOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
RSI: OversoldSep 26, 20224 years ago
MACD: Sell SignalSep 19, 20224 years ago
MACD: Buy SignalSep 5, 20224 years ago
MACD: Sell SignalAug 29, 20224 years ago
SMA: BearishAug 22, 20224 years ago
MACD: Buy SignalAug 8, 20224 years ago
SMA: BullishJul 25, 20224 years ago
RSI: OversoldJul 4, 20224 years ago
RSI: OversoldJun 6, 20224 years ago
SMA: BearishApr 18, 20224 years ago
SMA: BullishMar 14, 20224 years ago
SMA: BearishMar 7, 20224 years ago
SMA: BullishFeb 21, 20224 years ago

Key statistics

Market cap
127.03B
Enterprise value
143.44B
Trailing P/E
24.40
Forward P/E
15.50
PEG ratio
1.73
Price / sales
3.38
Price / book
2.53
EPS (TTM)
4.07
Beta
0.57
Dividend yield
2.98%
Payout ratio
70.02%
Profit margin
13.93%
Revenue (TTM)
37.54B
Revenue growth
13.70%
Free cash flow
5.41B
Total cash
8.82B
Total debt
28.15B
Return on equity
10.65%
Shares outstanding
1.28B
Short % of float
10.89%
50-day average
91.70
200-day average
88.16

Analyst view

Consensus: buy

Buy
Price target (mean) 104.62 +5.4% upside
Target (low)
85.00
Target (mean)
104.62
Target (high)
121.00
Ratings (0m) 30 20 buy · 10 hold · 0 sell
  • Strong buy3
  • Buy17
  • Hold10
  • Sell0
  • Strong sell0

Next earnings

Nov 17, 2026

Expected Nov 17, 2026. Consensus EPS estimate 1.33.

Earnings history

Financials — quick view

All financials
MDT Revenue — quarterly 9.76B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT Net income — quarterly 1.47B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT EPS — quarterly 1.15
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

MDT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 17, 2026Oct 31, 20261.33———
Sep 1, 2026Jul 31, 20261.391.45+0.06+4.32%
Jun 3, 2026Apr 24, 20261.541.55+0.01+0.65%
Feb 17, 2026Jan 23, 20261.341.36+0.02+1.49%
Nov 18, 2025Oct 24, 20251.311.36+0.05+3.82%
Aug 19, 2025Jul 25, 20251.231.26+0.03+2.44%

Upgrades / downgrades

MDT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026BTIGmainBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026TD CowenreitBuyBuy
Sep 3, 2026UBSmainBuyBuy
Sep 2, 2026Truist SecuritiesreitHoldHold
Sep 2, 2026Wells FargomainOverweightOverweight

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Sector
Healthcare
Industry
Medical Devices
Country
Ireland

News

Your note

Sign in to keep a note on MDT — it syncs with the Stock Master app.

Insider holders

MDT insider holders
InsiderRelationLatest transactionDateShares held
ARNOLD CRAIGDirectorStock Award(Grant)Apr 26, 202642,185
CORONA GARY LOUISChief Financial OfficerStock Award(Grant)Jan 20, 202544,255
HOGAN RANDALL J IIIDirectorStock Award(Grant)Apr 26, 202648,998
KIIL HARRY SKIPOfficerSaleSep 15, 202642,186
MARINARO MICHAELOfficerStock Award(Grant)Aug 2, 2026117,420
MARTHA GEOFFREY SChief Executive OfficerStock Award(Grant)Aug 2, 2026327,866

Institution ownership

MDT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.91%114,020,78711.32BJun 29, 2026
Vanguard Capital Management LLC6.55%83,816,7358.32BJun 29, 2026
State Street Corporation4.96%63,399,3156.30BJun 29, 2026
Vanguard Portfolio Management LLC2.66%34,059,9673.38BJun 29, 2026
Geode Capital Management, LLC2.36%30,192,0153.00BJun 29, 2026
JPMORGAN CHASE & CO2.17%27,784,4712.76BJun 29, 2026

Fund ownership

MDT fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%40,757,4224.05BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.60%33,271,4573.30BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%17,056,2981.69BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%16,665,9821.66BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%15,820,5821.57BSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Value Index Fund0.96%12,221,6431.21BJun 29, 2026
Advertisement